Biospecimen Acquisition From Human Subjects
Condition: Prostate Cancer, Breast Cancer, Colon Cancer, Lung Cancer, Liver Cancer
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT00034216
Sponsor: National Cancer Institute (NCI)
Phase:
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: All
Inclusion Criteria:
- Patients with a known or suspected malignancy and healthy volunteers 18 years of age and older are eligible. Performance status of ECOG 0, 1, 2, or 3 for admission to this protocol. Ability to understand and the willingness to sign a written informed consent document. INCLUSION FOR APHERESIS: Note: Effective with Amendment CC, participants will no longer be asked to undergo apheresis. This content is being retained for historical reference. Hemoglobin greater than or equal to 10 mg/dL and platelet count > 75,000/mm(3) Weight greater than 25 kg HIV negative Prothrombin Time
- within normal limits Partial Thromboplastin Time
- within normal limits Medically indicated central line in place or adequate peripheral venous access
Exclusion Criteria:
- None.
View trial on ClinicalTrials.gov